Pantoprazol 1 A Pharma (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol 1 A Pharma, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, and Zollinger‑Ellison syndrome in adults.

GNH USA supplies Pantoprazol 1 A Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, ensuring product integrity throughout the supply chain.

Pantoprazole is indicated for several acid‑related gastrointestinal conditions.

- Gastro‑oesophageal reflux disease (GERD): relief of heartburn and healing of erosive esophagitis. - Zollinger‑Ellison syndrome: control of gastric acid hypersecretion. - NSAID‑induced gastric ulcer: prevention and treatment of ulceration. - Helicobacter pylori eradication (as part of combination therapy): enhances eradication rates.

Pantoprazole may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate pain. - Diarrhea: loose stools. - Nausea: feeling of sickness. - Abdominal pain: discomfort in the stomach area. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis. - Severe allergic reactions: rash, swelling, anaphylaxis. - Low magnesium levels: hypomagnesemia with muscle cramps or arrhythmia. - Bone fractures: increased risk with long‑term use.

Before initiating pantoprazole therapy, several precautionary measures should be considered. - Renal or hepatic impairment: assess function and adjust use if needed. - Elderly patients: monitor for increased sensitivity to side effects. - Long‑term therapy: evaluate necessity regularly to avoid unnecessary exposure. - Concomitant medications: review for potential interactions, especially with drugs requiring acidic pH. - Magnesium monitoring: check serum magnesium during prolonged treatment. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Pantoprazole can affect the pharmacokinetics of several medicines; interactions are classified by clinical significance.

Major Interactions (Avoid): - Ketoconazole: reduced absorption due to increased gastric pH. - Atazanavir: markedly decreased plasma concentrations. - Itraconazole: decreased efficacy from impaired absorption. - Nelfinavir: reduced exposure leading to therapeutic failure. - Voriconazole: lowered serum levels compromising antifungal activity.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in anticoagulant effect. - Digoxin: altered absorption may change serum levels. - Methotrexate: reduced clearance may raise toxicity risk. - Calcium carbonate: may affect acid suppression efficacy. - Iron salts: decreased iron absorption.